Tags

Type your tag names separated by a space and hit enter

Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.
FASEB J. 2017 11; 31(11):4855-4865.FJ

Abstract

Osteoporosis is a metabolic bone disease characterized by decreased bone density and strength due to excessive loss of bone protein and mineral content. The imbalance between osteogenesis by osteoblasts and osteoclastogenesis by osteoclasts contributes to the pathogenesis of postmenopausal osteoporosis. Estrogen withdrawal leads to increased levels of proinflammatory cytokines. Overactivated osteoclasts by inflammation play a vital role in the imbalance. Matrine is an alkaloid found in plants from the Sophora genus with various pharmacological effects, including anti-inflammatory activity. Here we demonstrate that matrine significantly prevented ovariectomy-induced bone loss and inhibited osteoclastogenesis in vivo with decreased serum levels of TRAcp5b, TNF-α, and IL-6. In vitro matrine significantly inhibited osteoclast differentiation induced by receptor activator for NF-κB ligand (RANKL) and M-CSF in bone marrow monocytes and RAW264.7 cells as demonstrated by tartrate-resistant acid phosphatase (TRAP) staining and actin-ring formation as well as bone resorption through pit formation assays. For molecular mechanisms, matrine abrogated RANKL-induced activation of NF-κB, AKT, and MAPK pathways and suppressed osteoclastogenesis-related marker expression, including matrix metalloproteinase 9, NFATc1, TRAP, C-Src, and cathepsin K. Our study demonstrates that matrine inhibits osteoclastogenesis through modulation of multiple pathways and that matrine is a promising agent in the treatment of osteoclast-related diseases such as osteoporosis.-Chen, X., Zhi, X., Pan, P., Cui, J., Cao, L., Weng, W., Zhou, Q., Wang, L., Zhai, X. Zhao, Q., Hu, H., Huang, B., Su, J. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis.

Authors+Show Affiliations

Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. China-South Korea Bioengineering Center, Shanghai, China.Graduate Management Unit, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China; and.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. China-South Korea Bioengineering Center, Shanghai, China.Graduate Management Unit, Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China; and.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. China-South Korea Bioengineering Center, Shanghai, China.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. China-South Korea Bioengineering Center, Shanghai, China.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. China-South Korea Bioengineering Center, Shanghai, China.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China. China-South Korea Bioengineering Center, Shanghai, China.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China.China-South Korea Bioengineering Center, Shanghai, China. School of Pharmacy, Second Military Medical University, Shanghai, China.China-South Korea Bioengineering Center, Shanghai, China. School of Pharmacy, Second Military Medical University, Shanghai, China.China-South Korea Bioengineering Center, Shanghai, China.Department of Orthopedics Trauma and Shanghai Changhai Hospital, Second Military Medical University, Shanghai, China; drsujiacan@163.com. China-South Korea Bioengineering Center, Shanghai, China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

28739641

Citation

Chen, Xiao, et al. "Matrine Prevents Bone Loss in Ovariectomized Mice By Inhibiting RANKL-induced Osteoclastogenesis." FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, vol. 31, no. 11, 2017, pp. 4855-4865.
Chen X, Zhi X, Pan P, et al. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB J. 2017;31(11):4855-4865.
Chen, X., Zhi, X., Pan, P., Cui, J., Cao, L., Weng, W., Zhou, Q., Wang, L., Zhai, X., Zhao, Q., Hu, H., Huang, B., & Su, J. (2017). Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology, 31(11), 4855-4865. https://doi.org/10.1096/fj.201700316R
Chen X, et al. Matrine Prevents Bone Loss in Ovariectomized Mice By Inhibiting RANKL-induced Osteoclastogenesis. FASEB J. 2017;31(11):4855-4865. PubMed PMID: 28739641.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. AU - Chen,Xiao, AU - Zhi,Xin, AU - Pan,Panpan, AU - Cui,Jin, AU - Cao,Liehu, AU - Weng,Weizong, AU - Zhou,Qirong, AU - Wang,Lin, AU - Zhai,Xiao, AU - Zhao,Qingiie, AU - Hu,Honggang, AU - Huang,Biaotong, AU - Su,Jiacan, Y1 - 2017/07/24/ PY - 2017/04/09/received PY - 2017/07/05/accepted PY - 2017/7/26/pubmed PY - 2017/11/29/medline PY - 2017/7/26/entrez KW - NFATc1 KW - osteoclasts KW - postmenopausal osteoporosis SP - 4855 EP - 4865 JF - FASEB journal : official publication of the Federation of American Societies for Experimental Biology JO - FASEB J VL - 31 IS - 11 N2 - Osteoporosis is a metabolic bone disease characterized by decreased bone density and strength due to excessive loss of bone protein and mineral content. The imbalance between osteogenesis by osteoblasts and osteoclastogenesis by osteoclasts contributes to the pathogenesis of postmenopausal osteoporosis. Estrogen withdrawal leads to increased levels of proinflammatory cytokines. Overactivated osteoclasts by inflammation play a vital role in the imbalance. Matrine is an alkaloid found in plants from the Sophora genus with various pharmacological effects, including anti-inflammatory activity. Here we demonstrate that matrine significantly prevented ovariectomy-induced bone loss and inhibited osteoclastogenesis in vivo with decreased serum levels of TRAcp5b, TNF-α, and IL-6. In vitro matrine significantly inhibited osteoclast differentiation induced by receptor activator for NF-κB ligand (RANKL) and M-CSF in bone marrow monocytes and RAW264.7 cells as demonstrated by tartrate-resistant acid phosphatase (TRAP) staining and actin-ring formation as well as bone resorption through pit formation assays. For molecular mechanisms, matrine abrogated RANKL-induced activation of NF-κB, AKT, and MAPK pathways and suppressed osteoclastogenesis-related marker expression, including matrix metalloproteinase 9, NFATc1, TRAP, C-Src, and cathepsin K. Our study demonstrates that matrine inhibits osteoclastogenesis through modulation of multiple pathways and that matrine is a promising agent in the treatment of osteoclast-related diseases such as osteoporosis.-Chen, X., Zhi, X., Pan, P., Cui, J., Cao, L., Weng, W., Zhou, Q., Wang, L., Zhai, X. Zhao, Q., Hu, H., Huang, B., Su, J. Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis. SN - 1530-6860 UR - https://www.unboundmedicine.com/medline/citation/28739641/Matrine_prevents_bone_loss_in_ovariectomized_mice_by_inhibiting_RANKL_induced_osteoclastogenesis_ L2 - https://doi.org/10.1096/fj.201700316R DB - PRIME DP - Unbound Medicine ER -